ILDR2
Immunoglobulin-like domain-containing receptor 2
Also known as: C1orf32, ILDR2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q71H61
- Gene
- ILDR2
- Ensembl
- ENSG00000143195
- Chromosome
- 1
- Canonical length
- 639 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
Involved in negative regulation of T cell activation. Predicted to be located in tight junction. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
639 residues, UniProt reviewed canonical sequence.
>Q71H61|ILDR2
1 MDRVLLRWIS LFWLTAMVEG LQVTVPDKKK VAMLFQPTVL RCHFSTSSHQ PAVVQWKFKS
61 YCQDRMGESL GMSSTRAQSL SKRNLEWDPY LDCLDSRRTV RVVASKQGST VTLGDFYRGR
121 EITIVHDADL QIGKLMWGDS GLYYCIITTP DDLEGKNEDS VELLVLGRTG LLADLLPSFA
181 VEIMPEWVFV GLVLLGVFLF FVLVGICWCQ CCPHSCCCYV RCPCCPDSCC CPQALYEAGK
241 AAKAGYPPSV SGVPGPYSIP SVPLGGAPSS GMLMDKPHPP PLAPSDSTGG SHSVRKGYRI
301 QADKERDSMK VLYYVEKELA QFDPARRMRG RYNNTISELS SLHEEDSNFR QSFHQMRSKQ
361 FPVSGDLESN PDYWSGVMGG SSGASRGPSA MEYNKEDRES FRHSQPRSKS EMLSRKNFAT
421 GVPAVSMDEL AAFADSYGQR PRRADGNSHE ARGGSRFERS ESRAHSGFYQ DDSLEEYYGQ
481 RSRSREPLTD ADRGWAFSPA RRRPAEDAHL PRLVSRTPGT APKYDHSYLG SARERQARPE
541 GASRGGSLET PSKRSAQLGP RSASYYAWSP PGTYKAGSSQ DDQEDASDDA LPPYSELELT
601 RGPSYRGRDL PYHSNSEKKR KKEPAKKTND FPTRMSLVVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ILDR2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 9.8 nTPM
Expression across tissuesHPA
Tissue
- retina: 9.8 nTPM
- testis: 8.2 nTPM
- cerebral cortex: 6 nTPM
- hypothalamus: 3.2 nTPM
- amygdala: 2.9 nTPM
- kidney: 2.6 nTPM
Single-cell type
- müller glia: 283 nCPM
- sertoli cells: 187 nCPM
- oligodendrocyte progenitor cells: 184 nCPM
- cardiomyocytes: 129 nCPM
- podocytes: 98 nCPM
- choroid plexus epithelial cells: 62 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- thalamus: 48 nTPM
- cerebral cortex: 39 nTPM
- basal ganglia: 35 nTPM
- amygdala: 32 nTPM
- hypothalamus: 30 nTPM
- hippocampal formation: 29 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ILDR2.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 103 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.34
- gnomAD pLI
- 0.95
- gnomAD missense Z
- 1.26
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- homeostasis of number of cells within a tissue
- insulin secretion
- negative regulation of T cell activation
- pancreas development
- regulation of RNA splicing
- response to glucose
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ILDR2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ILDR2 as an antibody target. Whether an autoantibody or antibody against ILDR2 could matter depends on whether native ILDR2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ILDR2 is annotated at the cell surface, where native ILDR2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ILDR2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...